ATE485281T1 - Triazinderivate und deren verwendung als sonnenschutzmittel - Google Patents
Triazinderivate und deren verwendung als sonnenschutzmittelInfo
- Publication number
- ATE485281T1 ATE485281T1 AT02772133T AT02772133T ATE485281T1 AT E485281 T1 ATE485281 T1 AT E485281T1 AT 02772133 T AT02772133 T AT 02772133T AT 02772133 T AT02772133 T AT 02772133T AT E485281 T1 ATE485281 T1 AT E485281T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- alkyl
- unsubstituted
- substituted
- alkoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
- C07D251/70—Other substituted melamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01810796 | 2001-08-17 | ||
| CH16992001 | 2001-09-14 | ||
| PCT/EP2002/008888 WO2003016289A1 (en) | 2001-08-17 | 2002-08-08 | Triazine derivatives and their use as sunscreens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE485281T1 true ATE485281T1 (de) | 2010-11-15 |
Family
ID=25739004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02772133T ATE485281T1 (de) | 2001-08-17 | 2002-08-08 | Triazinderivate und deren verwendung als sonnenschutzmittel |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7038046B2 (de) |
| EP (1) | EP1423371B1 (de) |
| JP (1) | JP4344241B2 (de) |
| AT (1) | ATE485281T1 (de) |
| DE (1) | DE60238066D1 (de) |
| DK (1) | DK1423371T3 (de) |
| WO (1) | WO2003016289A1 (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7574545B2 (en) * | 2000-10-16 | 2009-08-11 | Electronics For Imaging, Inc. | Method and apparatus for controlling a document output device with a control request stored at a server |
| US6748471B1 (en) * | 2000-10-16 | 2004-06-08 | Electronics For Imaging, Inc. | Methods and apparatus for requesting and receiving a print job via a printer polling device associated with a printer |
| FR2867188A1 (fr) * | 2004-03-03 | 2005-09-09 | Oreal | Derives de s-triazine possedant un groupement para-alcoxyphenyle et au moins un groupement aminobenzalmaloniques greffes ; compositions cosmetiques contenant ces derives; utilisations desdits derives de s-tri |
| US20070286827A1 (en) * | 2006-06-12 | 2007-12-13 | Esschem, Inc. | Optical brighter and uv stabilizer for acrylic enhancements |
| US20080026109A1 (en) * | 2006-06-29 | 2008-01-31 | Martek Biosciences Corporation | Sweetened Oil Compositions and Methods of Making |
| CA2660527C (en) * | 2006-08-23 | 2014-09-23 | Unilever Plc | Photostable cosmetic compositions |
| US20080096782A1 (en) * | 2006-10-19 | 2008-04-24 | L'oreal | Aqueous systems containing phospholipid, surfactant and phosphate ester for water-insoluble materials |
| US20080097070A1 (en) * | 2006-10-19 | 2008-04-24 | L'oreal | Aqueous polyamine-containing systems for water-insoluble materials |
| ES2740424T3 (es) | 2009-03-13 | 2020-02-05 | Agios Pharmaceuticals Inc | Métodos y composiciones para trastornos relacionados con la proliferación celular |
| SG177434A1 (en) | 2009-06-29 | 2012-02-28 | Agios Pharmaceuticals Inc | Therapeutic compounds and compositions |
| ES2594402T3 (es) | 2009-10-21 | 2016-12-20 | Agios Pharmaceuticals, Inc. | Métodos y composiciones para trastornos relacionados con la proliferación celular |
| JP5846696B2 (ja) | 2010-05-10 | 2016-01-20 | サジティス・インコーポレイテッド | アルキルケタールエステルを含有する個別健康管理用処方物および製造方法 |
| WO2012091088A1 (ja) * | 2010-12-28 | 2012-07-05 | 日産化学工業株式会社 | ポリイミド膜形成用塗布液、液晶配向剤、ポリイミド膜、液晶配向膜及び液晶表示素子 |
| WO2012092546A2 (en) * | 2010-12-30 | 2012-07-05 | L'oreal S.A. | Mascara compositions containing an oil-dispersible micronized wax and a water-dispersible wax |
| PH12013502241A1 (en) | 2011-05-03 | 2014-01-06 | Agios Pharmaceuticals Inc | Pyruvate kinase activators for use in therapy |
| CN102827073A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| CN102827170A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| HUE038403T2 (hu) | 2012-01-06 | 2018-10-29 | Agios Pharmaceuticals Inc | Terápiásan alkalmazható vegyületek és alkalmazási módszereik |
| US9474779B2 (en) | 2012-01-19 | 2016-10-25 | Agios Pharmaceuticals, Inc. | Therapeutically active compositions and their methods of use |
| CA2888360A1 (en) | 2012-10-15 | 2014-04-24 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
| WO2015003360A2 (en) * | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| WO2015003355A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| US9579324B2 (en) | 2013-07-11 | 2017-02-28 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| CA2917592A1 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as idh2 mutants inhibitors for the treatment of cancer |
| AU2014287121B2 (en) | 2013-07-11 | 2018-11-15 | Agios Pharmaceuticals, Inc. | 2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer |
| US20150031627A1 (en) | 2013-07-25 | 2015-01-29 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| WO2015138839A1 (en) | 2014-03-14 | 2015-09-17 | Agios Pharmaceuticals, Inc. | Pharmaceutical compositions of therapeutically active compounds |
| EP4344703A1 (de) | 2015-06-11 | 2024-04-03 | Agios Pharmaceuticals, Inc. | Verfahren zur verwendung von pyruvatkinaseaktivatoren |
| PT3362066T (pt) | 2015-10-15 | 2021-11-16 | Celgene Corp | Terapia de combinação para tratar malignidades |
| MD3362065T2 (ro) | 2015-10-15 | 2024-08-31 | Servier Lab | Terapie combinată care conține ivosidenib, citarabină și daunorubicina sau idarubicina pentru tratarea leucemiei acute mielogene |
| CN107827764A (zh) * | 2017-11-27 | 2018-03-23 | 上海应用技术大学 | 一种双β‑氨基酮或双β‑氨基酯类的制备方法 |
| US10980788B2 (en) | 2018-06-08 | 2021-04-20 | Agios Pharmaceuticals, Inc. | Therapy for treating malignancies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4105923A1 (de) * | 1991-02-26 | 1992-08-27 | Basf Ag | P-aminozimtsaeure-substituierte triazine |
| DE4223890A1 (de) * | 1992-02-19 | 1993-08-26 | Merck Patent Gmbh | Triazin-derivate |
| FR2744721B1 (fr) * | 1996-02-12 | 1999-06-18 | Oreal | Nouveaux derives insolubles de s-triazine, leur procede de preparation, compositions les contenant et leurs utilisations |
-
2002
- 2002-08-08 AT AT02772133T patent/ATE485281T1/de not_active IP Right Cessation
- 2002-08-08 US US10/486,761 patent/US7038046B2/en not_active Expired - Lifetime
- 2002-08-08 EP EP02772133A patent/EP1423371B1/de not_active Expired - Lifetime
- 2002-08-08 DE DE60238066T patent/DE60238066D1/de not_active Expired - Lifetime
- 2002-08-08 DK DK02772133.1T patent/DK1423371T3/da active
- 2002-08-08 JP JP2003521215A patent/JP4344241B2/ja not_active Expired - Fee Related
- 2002-08-08 WO PCT/EP2002/008888 patent/WO2003016289A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003016289A1 (en) | 2003-02-27 |
| EP1423371B1 (de) | 2010-10-20 |
| JP2005501855A (ja) | 2005-01-20 |
| EP1423371A1 (de) | 2004-06-02 |
| JP4344241B2 (ja) | 2009-10-14 |
| US7038046B2 (en) | 2006-05-02 |
| DK1423371T3 (da) | 2011-02-07 |
| US20040242579A1 (en) | 2004-12-02 |
| DE60238066D1 (de) | 2010-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE485281T1 (de) | Triazinderivate und deren verwendung als sonnenschutzmittel | |
| DK0671161T3 (da) | Ectoin og ectoinderivater som fugtighedsgiver i kosmetikprodukter | |
| HUP0203841A2 (en) | 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them | |
| JP2005538072A5 (de) | ||
| HUP0300641A2 (hu) | Triazaspiro[5.5]undekán-származékok és hatóanyagként ezeket tartalmazó gyógyszerkészítmények | |
| BR9908764A (pt) | Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica | |
| HUP0004259A2 (hu) | VLA-4 által mediált leukocita adhéziót gátló szubsztituált fenilalanin-származékok, ezeket tartalmazó gyógyászati készítmények | |
| ZA200401461B (en) | Heterocyclic compound based on n6 substituted adenine methods of their preparation their use for preparation of drugs cosmetic preparations and growth regulators pharmaceutical prepartion cosmetic preparations and growth regulators containing these compou | |
| HUP0003929A2 (hu) | Piperazinszármazékok és alkalmazásuk gyulladásgátló hatású gyógyszerkészítmények előállítására, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
| ATE174917T1 (de) | Pyrazolo(1,5-a>pyrimidinderivate und sie enthaltende antiinflammatorische mittel | |
| JP2005501855A5 (de) | ||
| HUP0402352A2 (hu) | Foszfodiészteráz (PDE) 7 inhibitorként alkalmazható pirimidinszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0004531A2 (hu) | VLA-4 által mediált leukocita adhéziót gátló 4-aminofenilalanin-vegyületek, ezeket tartalmazó gyógyászati készítmények, valamint alkalmazásuk | |
| DE69720535D1 (de) | Die wirkstoffresistenz in der krebs-chemotherapie umkehrende taxoide mittel und pharmazeutische zubereitungen davon | |
| CA2473228A1 (en) | Sunscreen compositions as well as dihydropyridines and dihydropyranes | |
| DK0585155T3 (da) | Trifluormethylketon-peptidderivater med HLE-inhiberende aktivitet, deres fremstilling og farmaceutiske præparater | |
| HUP0500017A2 (hu) | Alkil-éter-származékok, sóik és az ezeket tartalmazó gyógyszerkészítmények | |
| NO20000313L (no) | Nye forbindelser | |
| HUP9801528A2 (hu) | Zöld porfirinek alkalmazása immunomodulátor hatású gyógyszerkészítmények előállítására | |
| HUP0101960A2 (hu) | Az ekteinaszcidin 743 metabolitjai, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| CA2124315A1 (en) | Nitroaniline derivatives and their use as antitumor agents | |
| AR024904A1 (es) | Derivados de pirrol heteroaril sustituidos, su preparacion y sus usos terapeuticos. | |
| HUP0301030A2 (hu) | Kardiális aritmiák kezelésére alkalmazható új aza-biciklooktán-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| EP0321968A3 (en) | Compounds active on the cardiovascular system | |
| ATE131030T1 (de) | Indolin-produkte, ihren verfahren zu deren herstellung sowie ihren verwendung in der kosmetik. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |